| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3586cd5bcaf47351fbdef95e9d1fba0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d94b9abca7ae09fd0101e3d877a21e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2008-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4cbbab38bfe3f7dc7409afa6febcfc3 |
| publicationDate |
2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008124121-A1 |
| titleOfInvention |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters |
| abstract |
Co-therapy of an 1,4-dihydropyridine-3,5-dicarboxyldiester and a statin is disclosed along with fixed combinations thereof. Amorphous atorvastatin hemicalcium salt and amlodipine besylate are preferred as the various components. |
| priorityDate |
2007-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |